Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Executive misalignment slows AI value and growth despite rising investments, says Protiviti survey.

Market News
25 Jun 2026
PRNewsWire
View Source
Neutral
pluang ai news

A Protiviti Global Transformation Survey of 852 C-suite executives reveals a significant gap between CEOs and technology leaders on AI's business impact, with CEOs less confident in AI-driven revenue growth than CIOs/CTOs. The study finds that strong executive alignment correlates with higher confidence in AI value realization and transformation success. Key barriers include workforce skill gaps, data governance, and cybersecurity concerns. To improve outcomes, organizations should align leadership on success metrics and communication, ensuring AI investments support long-term transformation and growth.

More News

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...

Company Fundamentals
Neutral
40 minutes ago
Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...

Company Fundamentals
Neutral
40 minutes ago
Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...

Market News
Neutral
41 minutes ago
Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...

Market News
Neutral
41 minutes ago
Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App